<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> is similar to but a separate entity from both myeloproliferative <z:hpo ids='HP_0002664'>neoplasms</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, and shows either myeloproliferative or myelodysplastic features </plain></SENT>
<SENT sid="1" pm="."><plain>We ask whether this distinction may have a molecular basis </plain></SENT>
<SENT sid="2" pm="."><plain>We established the gene expression profiles of 39 samples of <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (including 12 CD34-positive) and 32 CD34-positive samples of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> by using Affymetrix microarrays, and studied the status of 18 genes by Sanger sequencing and array-comparative genomic hybridization in 53 samples </plain></SENT>
<SENT sid="3" pm="."><plain>Analysis of 12 mRNAS from <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> established a gene expression signature of 122 probe sets differentially expressed between proliferative and dysplastic cases of <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>As compared to proliferative cases, dysplastic cases over-expressed genes involved in red blood cell biology </plain></SENT>
<SENT sid="5" pm="."><plain>When applied to 32 <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, this gene expression signature was able to discriminate <z:hpo ids='HP_0005505'>refractory anemias</z:hpo> with ring sideroblasts from <z:hpo ids='HP_0005505'>refractory anemias</z:hpo> with excess of blasts </plain></SENT>
<SENT sid="6" pm="."><plain>By comparing mRNAS from these two forms of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> we derived a second gene expression signature </plain></SENT>
<SENT sid="7" pm="."><plain>This signature separated the myelodysplastic and myeloproliferative forms of <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>These results were validated using two independent gene expression data sets </plain></SENT>
<SENT sid="9" pm="."><plain>We found that myelodysplastic <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemias</z:hpo> are characterized by mutations in transcription/epigenetic regulators (ASXL1, RUNX1, TET2) and splicing genes (SRSF2) and the absence of mutations in signaling genes </plain></SENT>
<SENT sid="10" pm="."><plain>Myelodysplastic <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemias</z:hpo> and <z:hpo ids='HP_0005505'>refractory anemias</z:hpo> with ring sideroblasts share a common expression program suggesting they are part of a continuum, which is not totally explained by their similar but not, however, identical mutation spectrum </plain></SENT>
</text></document>